[Cytogenetic and molecular genetic changes in malignant primary bone tumors]

Area of Science:

• Orthopedic oncology
• Skeletal tumor pathology
• Cancer genetics

Context:

• The Rizzoli Orthopedic Institute archives contain over 4423 malignant bone tumors diagnosed since 1920.
• Osteosarcoma, chondrosarcoma, and Ewing tumors are the most prevalent primary malignant bone tumors.
• Less common malignant bone tumors include malignant fibrous histiocytoma, fibrosarcoma, and giant-cell tumors.

Purpose:

• To review the spectrum of primary malignant bone tumors.
• To highlight the current understanding of genetic aberrations in these tumors.
• To emphasize the unique genetic marker identified in Ewing tumors.

Summary:

• A significant number of primary malignant bone tumors, including osteosarcoma, chondrosarcoma, and Ewing tumors, are documented in the Rizzoli Orthopedic Institute's archives.
• While advancements in molecular and cytogenetic techniques have increased knowledge of genetic abnormalities in bone tumors, a recurrent chromosomal marker has only been identified for Ewing tumors.
• This specific marker is the translocation t(11;22) (q24;q12).

Impact:

• Provides a historical overview of primary malignant bone tumor diagnoses.
• Underscores the importance of genetic research in understanding bone malignancies.
• Highlights a key genetic finding in Ewing tumors, potentially aiding future diagnostics and targeted therapies.